Neurocrine Highlights INGREZZA's Long-Term Efficacy & Safety In Older Adults With Tardive Dyskinesia
25/4 04:43
(RTTNews) - Neurocrine Biosciences Inc. (NBIX) announced publication of a post-hoc analysis from two 48-week studies, the KINECT 3 extension and KINECT 4, demonstrating the long-term safety profile and robust efficacy of INGREZZA (valbenazine) capsules in adults aged 65 years and...